Stockscreener 앱 받기
1.12
2.61%
-0.03
시간 외 거래:
1.10
-0.02
-1.79%
Sunshine Biopharma Inc 주식(SBFM)의 최신 뉴스
Sunshine Biopharma earnings beat by $0.05, revenue topped estimates - Investing.com
L1 Capital (SBFM) discloses 4.99% Sunshine Biopharma stake plus large warrant position - Stock Titan
Sunshine Biopharma Inc (NASDAQ: SBFM) Share Price, SBFM Stock News, SBFM Share Price & Updates - kalkine.ca
Sunshine Biopharma (SBFM) investors cap warrant-driven stake at 9.99% - Stock Titan
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market - The Lawton Constitution
SBFM Stock Holds Support As Traders Eye Next Move - timothysykes.com
SBFM Stock Holds Support As Sunshine Biopharma Tightens Cash Control - StocksToTrade
SBFM Stock Holds Range As Traders Weigh Weak Margins - timothysykes.com
SBFM Stock Slides As Traders Focus On Cash Runway And Volatility - StocksToTrade
SBFM Stock Pops As Health Canada Greenlights New Generics - StocksToTrade
Amoxicillin Market Estimated at $4.9B as Canada Shipments Begin - Stock Titan
Sunshine Biopharma Inc. Revenue Breakdown – NASDAQ:SBFMW - TradingView
SBFM Looks 84.2% Undervalued on GF Value™ Despite Distressed Fun - GuruFocus
Sunshine Biopharma receives Canadian approval for generic dienogest By Investing.com - Investing.com Nigeria
Sunshine Biopharma receives Canadian approval for generic dienogest - Investing.com
Sunshine Biopharma's 2mg Tablet for Endometriosis Pain Wins Canadian Approval - Stock Titan
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval - Benzinga
SBFM Q2'26 Earnings: EPS estimate is (1.20) USD - TradingView
Sunshine Biopharma wins Canadian approval for generic Dienogest tablets - Bitget
Sunshine Biopharma cuts exercise price of outstanding Series B warrants to $1.22 - Bitget
Sunshine Biopharma Inc. (SBFM) Q1 2026 Earnings: Loss Per Share Widens as Revenue Remains ZeroPeak Earnings Alert - dars.gov.et
SBFM Looks 79.1% Undervalued on GF Value™ Amid Challenging Finan - GuruFocus
Sunshine Biopharma receives Canadian approval for ondansetron - Investing.com
Sunshine Biopharma receives Canadian approval for ondansetron By Investing.com - Investing.com Canada
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting - New Castle News
Sunshine Biopharma Inc (SBFM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SBFM|Sunshine Biopharma Inc|Price:1.696| - TradingKey
Sunshine Biopharma Inc (SBFM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SBFM|Sunshine Biopharma Inc|Price:1.230|Chg%:-0.170 - TradingKey
Sunshine Biopharma Inc. (SBFM) Q1 2026 Earnings: Continued R&D Investment Drives Net Loss, No Revenue ReportedEarnings Outlook Update - dars.gov.et
Sunshine Biopharma Inc. Revenue Breakdown – NASDAQ:SBFM - TradingView
Sunshine Biopharma Inc. Revenue Breakdown – BOATS:SBFMW - TradingView
Sunshine Biopharma Inc (SBFM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Price to sales forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
Sunshine Biopharma Announces ATM Equity Sales Agreement - The Globe and Mail
Sunshine Biopharma plans up to $4 million at-the-market share sale via Aegis Capital - Bitget
Sunshine BiopharmaEnters At-The-Market Sales Agreement With Aegis Capital For Up To $4 MillionSEC Filing - TradingView
Sunshine Biopharma announces publication of new results on MR1-114 - TipRanks
Sunshine Biopharma (SBFM) Reports Breakthrough Research on SARS-CoV-2 Treatment - GuruFocus
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings - The Daily Corinthian
Form DEF 14A Sunshine Biopharma Inc For: 16 July By Investing.com - Investing.com Canada
Sunshine Biopharma (SBFM) Eases 1.5% as Stock Tests Support Near $1.82Debt Free Companies - dars.gov.et
Sunshine Biopharma stock rallies on Canadian approval for generic amoxicillin - MSN
Sunshine Biopharma Settles Dispute With Former Nora President - The Globe and Mail
Sunshine Biopharma (NASDAQ: SBFM) pays CAD$1.5M to settle Nora Pharma dispute - Stock Titan
Sunshine Biopharma (SBFM) Posts Modest Gain Amid Narrow Trading RangeHead and Shoulders - dars.gov.et
Alta Partners LLC reports 200,000 shares in Sunshine Biopharma (SBFM) - Stock Titan
Sunshine Biopharma Company Profile & Introduction - Moomoo
Enterprise value to EBITDA forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
Enterprise value to EBIT forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
SBFM Q1 2026 Earnings: Pre-Revenue Biotech Reports Narrowed Loss, Stock RisesRevenue Surprise History - po-news-eg.net
Price to earnings forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
Sunshine Biopharma(SBFM) Stock Options Chain | Quotes & News - Moomoo
Sunshine Biopharma (SBFM) Dips 3.2% as Stock Nears Key Support at $2.00IV Rank - dars.gov.et
SBFM Q1 2026 Earnings: Pre-Revenue Biopharma Reports Net Loss Per Share of -$0.25Trough Earnings Signal - DonanımHaber
Sunshine Biopharma (SBFM) Edges Higher Amid Sector Support – Key Levels to WatchCup and Handle - dars.gov.et
Sunshine Biopharma (SBFM) Edges Higher, Nears Resistance at $2.29Late Stage Breakouts - dars.gov.et
Sunshine Biopharma Inc. Q1 2026 Earnings: Narrowing Loss Reflects Ongoing Pipeline ProgressCFO Commentary Report - dars.gov.et
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R) - Black Hills Pioneer
Sunshine Biopharma Inc (SBFM) Valuation: PE, PB & Fair Value Analysis - TradingKey
1.61%
1.30%
자본화:
|
볼륨(24시간):